CorMedix (CRMD) Strengthens Management Team with Addition of Randy Milby as Chief Operating Officer
5/3/2012 10:41:16 AM
BRIDGEWATER, N.J.--(BUSINESS WIRE)--CorMedix Inc. (“CorMedix”) (NYSE Amex: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, today announced the appointment of Randy Milby as its Chief Operating Officer. Randy brings extensive commercial operational experience to the Company having worked as the Global Business Director of Applied Biosciences and other management positions at Dupont from 1999 through 2010. Prior to his experience with Dupont, he was also a Healthcare Analyst at Goldman Sachs & Company. Randy received his Pharmacy degree at the University of Kansas and his MBA from Washington University in St. Louis. Randy Milby has been employed from September 2010 to present at WaterStone Bridge LLC., a healthcare consulting firm.